Melanie J. Herman, Director of Accounting at LIGAND PHARMACEUTICALS INC (LGND), bought 98 shares at $43.79 ($4K) on 2014-06-30, disclosed to the SEC on 2014-07-01.
Open-market purchase of $4k LGND by Director of Accounting. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2015-06-11 | $386K | — | Filing → |
| LGND | SELL | 2015-03-03 | $32K | — | Filing → |
| LGND | SELL | 2015-02-20 | $29K | — | Filing → |